Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


BBC & UCL announce new strategic partnership

21 November 2012

BBC

BBC Research & Development today announced a new strategic partnership with UCL, to drive innovation, and collaborate on a wide programme of R&D activity.

Building on the BBC’s history of partnerships, this venture will bring together some of the brightest minds in the UK to discuss and tackle the challenges for digital media and the creative industry at large.

Over the next four years, the new partnership between BBC and UCL will focus on an ambitious programme of research work that seeks to advance state-of-the-art communications technologies, Internet research, content production, user experience (UXD) and access services. The outcomes of this research will also be shared with the wider industry.

Read the full article on UCL News